New-Onset T1D Trials
Many immunotherapy clinical trials target individuals who have recently been diagnosed with type 1 diabetes, with goals to preserve their beta cell function and prevent disease progression. Find the list of clinical trials offered in the area along with contact information and links to more information.
COUR CNP-103-CL-201
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Joslin Diabetes Center, Boston, MA
Actively Recruiting
GNTI-122 POLARIS
A Study of GNTI-122 in Adults Recently Diagnosed With T1D (POLARIS)
Joslin Diabetes Center, Boston, MA
Actively Recruiting
GentiBio HLA
HLA Demographics Study in Adults With Type 1 Diabetes
GentiBio HLA Study Website:
https://clinicaltrials.gov/study/NCT06860516?cond=diabetes&aggFilters=status:
Joslin Diabetes Center, Boston MA
Actively Recruiting
FABULINUS
FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy
Joslin Diabetes Center, Boston, MA
ACTIVELY Recruiting
DIAGNODE-3
A Phase III Study to Investigate If the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed with Type 1 Diabetes
Joslin Diabetes Center, Boston, MA
Recruiting
Carbohydrate Beta Cell Function and Glucose Control in Children With Diabetes
Testing the effects of a ketogenic diet on the progression and control of type 1 diabetes in children with newly diagnosed diabetes
Boston Children's Hospital, Boston, MA
GLADIATOR
A phase 3, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of 400 mg twice a day oral ladarixin in patients with recent onset type 1 diabetes and a low residual B-cell function at baseline.
Joslin Diabetes Center, Boston, MA
Clinical Trials Website
Not Recruiting
ITN DESIGNATE
A T cell phenotype signature driven dose finding study with siplizumab in type 1 diabetes mellitus
Joslin Diabetes Center, Boston, MA
DESIGNATE Study Website
Not Recruiting
T1D RELAY
Rituximab-pvvr / Abatacept Newly Diagnosed Study
Joslin Diabetes Center, Boston, MA
Naomi Berrie Diabetes Center, New York, NY
Yale University, New Haven, CT
T1D RELAY Trial Website
Not Recruiting
JAKPOT T1D
JAK Inhibitors Newly Diagnosed Study
Joslin Diabetes Center, Boston, MA
Naomi Berrie Diabetes Center, New York, NY
Yale University, New Haven, CT
JAKPOT T1D Trial Website
Not Recruiting
- The safety and scientific validity of a research study is the responsibility of the study investigators and the study sponsor.
- It is important to evaluate the risks and potential benefits of clinical studies and to talk to your health care provider(s) before participating in a study.